Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone

Periodic assessment of gene expression for diagnosis and monitoring in rheumatoid arthritis (RA) may provide a readily available and useful method to detect subclinical disease progression and follow responses to therapy with disease modifying anti-rheumatic agents (DMARDs) or anti-TNF-α therapy. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Carl K., Green, Julie S., Volk, Hans-Dieter, Schiff, Michael, Kotzin, Brian L., Mitsuya, Hiroaki, Kawaguchi, Tatsuya, Sakata, Ken-Mei, Cheronis, John, Trollinger, David, Bankaitis-Davis, Danute, Dinarello, Charles A., Norris, David A., Bevilacqua, Michael P., Fujita, Mayumi, Burmester, Gerd-Rudiger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525111/
https://www.ncbi.nlm.nih.gov/pubmed/23264777
http://dx.doi.org/10.3389/fimmu.2012.00366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525111/
https://www.ncbi.nlm.nih.gov/pubmed/23264777
http://dx.doi.org/10.3389/fimmu.2012.00366

Ejemplares similares